:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/IBNFBSMQOFEI5LYTNC3YAMK7Y4.jpg?fit=%2C&ssl=1)
The European Medicines Agency (EMA) considered this Wednesday that vaccination against COVID 19 can be administered “once a year” and warned that the virus “still represents a significant burden” for health systems in Europe, especially for the low rate of reinforcements in vulnerable groups. The agency “will continue to monitor emerging data over the coming […]
Tag: European Medicines Agency
European Medicines Agency explains that the fourth dose in immunocompromised patients is their “first booster”
Updated on 02/03/2022 09:55 am The European Medicines Agency (EMA) has urged giving a fourth dose of Pfizer or Moderna to people with severely weakened immune systems, explaining that it is considered a “first reinforcement”. The head of Vaccination Strategy, Marco Cavaleryexplained that for people with a severely compromised immune system who have already received […]
EU Regulator Gives Novavax Green Light As Fifth COVID Vaccine Of The Block
Updated on 12/20/2021 12:39 pm The European Medicines Agency (EMA) said on Monday that it has authorized the vaccine from the US company Novavax against COVID-19 for use in people aged 18 and over, paving the way for a fifth coronavirus vaccine in the EU as the omicron variant of the coronavirus spreads. Data from […]
European Medicines Agency refuses to license Aduhelm, a drug for Alzheimer’s
The European Medicines Agency (EMA) refused to endorse a license for the use in the European market of Aduhelm, a drug intended to directly treat Alzheimer’s, due to “contradictions” in the results of the main studies and the lack of data on its safety. The experts considered that “the link has not been established” between […]
European Medicines Agency supports license to use Xevudy and Kineret to treat COVID-19
The European Medicines Agency (EMA) endorsed the use in the European Union (EU) of two new treatments for COVID-19, the monoclonal antibody sotrovimab (Xevudy) in people over 12 years old and the immunosuppressive drug anakinra (Kineret) in adult patients. . Xevudy is recommended to treat COVID-19 in adults and adolescents from 12 years of age […]
European Medicines Agency approves combining different types of vaccines for COVID-19
Updated on 07/12/2021 09:42 am The European Medicines Agency (EMA) approved combining different types of vaccines against the COVID-19 coronavirus. The EMA indicated in a statement that the use of different types of vaccines, a process known as heterologous vaccination, can offer protection against COVID-19. The announcement comes as in much of Europe cases of […]
European Medicines Agency supports use of RoActemra in adults with severe COVID-19
Updated on 12/06/2021 12:46 pm The European Medicines Agency (EMA) endorsed the use of RoActemra (tocilizumab) – used in patients with rheumatoid arthritis – to treat adults with severe COVID-19 who are receiving corticosteroid treatment and need supplemental oxygen. The Committee for Medicinal Products for Human Use (CHMP) recommended extending the indication of RoActemra, already […]
EMA estimates that adapting vaccines to the omicron variant will take between three and four months
:quality(75)/cdn.jwplayer.com/v2/media/jA6tfqlE/poster.jpg?fit=%2C&ssl=1)
Updated on 11/30/2021 11:59 am The director of the European Medicines Agency, Emer Cooke, said on Tuesday that the agency has plans to accelerate the adaptation of vaccines to the new omicron variant if necessary, a process that he has estimated will take between three and four months. . In an intervention in the European […]